Literature DB >> 23817190

Optimal renin-angiotensin system blockade-wishful thinking?

Harikrishna Makani, Sripal Bangalore, Franz H Messerli.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23817190     DOI： 10.1038/nrcardio.2013.28-c1

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN： 1759-5002            Impact factor:   32.419


× No keyword cloud information.
  7 in total

1.  Effect of a triple blockade of the renin-angiotensin-system in recurrent focal segmental glomerulosclerosis after kidney transplantation.

Authors:  Verena Freiberger; Kerstin Amann; Uwe Heemann; Helga Frank
Journal:  Transpl Int       Date:  2009-05-20       Impact factor: 3.782

2.  Supramaximal dose of candesartan in proteinuric renal disease.

Authors:  Ellen Burgess; Norman Muirhead; Paul Rene de Cotret; Anthony Chiu; Vincent Pichette; Sheldon Tobe
Journal:  J Am Soc Nephrol       Date:  2009-02-11       Impact factor: 10.121

Review 3.  Renin-angiotensin system blockers may create more risk than reward for sodium-depleted cardiovascular patients with high plasma renin levels.

Authors:  Jean E Sealey; Michael H Alderman; Curt D Furberg; John H Laragh
Journal:  Am J Hypertens       Date:  2013-04-02       Impact factor: 2.689

4.  Additional antiproteinuric effect of ultrahigh dose candesartan: a double-blind, randomized, prospective study.

Authors:  Roland E Schmieder; Arnfried U Klingbeil; Erwin H Fleischmann; Roland Veelken; Christian Delles
Journal:  J Am Soc Nephrol       Date:  2005-08-24       Impact factor: 10.121

5.  Albuminuria response to very high-dose valsartan in type 2 diabetes mellitus.

Authors:  Norman K Hollenberg; Hans-Henrik Parving; Giancarlo Viberti; Giuseppe Remuzzi; Susan Ritter; Steven Zelenkofske; Albert Kandra; William L Daley; Ricardo Rocha
Journal:  J Hypertens       Date:  2007-09       Impact factor: 4.844

6.  Pharmacotherapy: Optimal blockade of the renin-angiotensin-aldosterone system.

Authors:  Jürg Nussberger; Jürgen Bohlender
Journal:  Nat Rev Cardiol       Date:  2013-03-12       Impact factor: 32.419

Review 7.  Efficacy and safety of dual blockade of the renin-angiotensin system: meta-analysis of randomised trials.

Authors:  Harikrishna Makani; Sripal Bangalore; Kavit A Desouza; Arpit Shah; Franz H Messerli
Journal:  BMJ       Date:  2013-01-28
  7 in total
  2 in total

1.  Reply: Optimal renin-angiotensin-aldosterone system blockade--wish fulfilled.

Authors:  Jürg Nussberger; Jürgen Bohlender
Journal:  Nat Rev Cardiol       Date:  2013-07-02       Impact factor: 32.419

Review 2.  Combination use of medicines from two classes of renin-angiotensin system blocking agents: risk of hyperkalemia, hypotension, and impaired renal function.

Authors:  Raquel Esteras; Maria Vanessa Perez-Gomez; Laura Rodriguez-Osorio; Alberto Ortiz; Beatriz Fernandez-Fernandez
Journal:  Ther Adv Drug Saf       Date:  2015-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.